pr-10363-preview.bioxconomy.com Open in urlscan Pro
2606:4700:4400::6812:2231  Public Scan

Form analysis
0 forms found in the DOM

Text Content

BioXconomy is part of the Informa Connect Division of Informa PLC
Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT
This site is operated by a business or businesses owned by Informa PLC and all
copyright resides with them. Informa PLC's registered office is 5 Howick Place,
London SW1P 1WG. Registered in England and Wales. Number 8860726.

AboutEventsAdvertise

Stay Updated

Stay Updated

Investment

RELATED TOPICS

 * VC/PE
 * Seed Funding

 * IPOs

RECENT IN INVESTMENT

See All
Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blastEyes on Asia:
GSK’s $300m lupus bet, Pfizer’s $1bn China blast
byRichard Daverman
Nov 18, 2024
5 Min Read
CMO Summit in Milan, Italy
Investment
IPOs on course for recovery but does biotech need public funding anymore?IPOs on
course for recovery but does biotech need public funding anymore?
byDan Stanton
Nov 12, 2024
4 Min Read
Innovation

RELATED TOPICS

 * Hubs
 * Academic Research

 * R&D Technology

RECENT IN INNOVATION

See All
Eli Lilly logo
Innovation
From east to west: Lilly plans incubators in China and UKFrom east to west:
Lilly plans incubators in China and UK
byMillie Nelson, Richard Daverman
Oct 18, 2024
2 Min Read
photo of a sunrise over solar panels/building
Innovation
Inside five innovative research companies driving progress in oncology and
neurologyInside five innovative research companies driving progress in oncology
and neurology
Sep 21, 2024
9 Min Read
Partnering

RELATED TOPICS

 * Licensing
 * M&A

 * Deals
 * Best Practices

RECENT IN PARTNERING

See All
Alzheimer's disease written in blocks
Partnering
AbbVie forks out $1.4bn to buy Alzheimer’s therapy developer AliadaAbbVie forks
out $1.4bn to buy Alzheimer’s therapy developer Aliada
byMillie Nelson
Oct 29, 2024
2 Min Read
thumbnail
Partnering
Top five Asia biopharma deals: August 2024Top five Asia biopharma deals: August
2024
byRichard Daverman
Sep 15, 2024
4 Min Read
Business Strategy

RELATED TOPICS

 * Scaling/Commercialization
 * Growth Strategy
 * ESG

 * Outsourcing
 * Legal

RECENT IN BUSINESS STRATEGY

See All
thumbnail
Business Strategy
Build trust by making healthcare fairer and more equitable, say expertsBuild
trust by making healthcare fairer and more equitable, say experts
byMillie Nelson
Oct 14, 2024
3 Min Read
thumbnail
Business Strategy
Building successful teams in biotech: “The future is female and very
colorful”Building successful teams in biotech: “The future is female and very
colorful”
byMillie Nelson
May 7, 2024
2 Min Read


Sponsored By



LATEST NEWS


EYES ON ASIA: GSK’S $300M LUPUS BET, PFIZER’S $1BN CHINA BLAST

Nov 18, 2024


IPOS ON COURSE FOR RECOVERY BUT DOES BIOTECH NEED PUBLIC FUNDING ANYMORE?

Nov 12, 2024


EUROPE’S ADVERSITY TO RISK IS WHY THE US IS AHEAD, SAY EXPERTS

Nov 5, 2024


CALL FOR SPECIFIC FEMALE HEALTH FUNDING TO TACKLE BIOTECH FINANCE GENDER GAP

Oct 30, 2024
More
Money
Investment


EYES ON ASIA: GSK’S $300M LUPUS BET, PFIZER’S $1BN CHINA BLAST


EYES ON ASIA: GSK’S $300M LUPUS BET, PFIZER’S $1BN CHINA BLAST

BioXconomy presents the Asia biopharma and healthcare dealmaking and financing
news for the week ending 8 November.

Nov 18, 2024
|
5 Min Read
CMO Summit in Milan, Italy
Investment
IPOs on course for recovery but does biotech need public funding anymore?
IPOs on course for recovery but does biotech need public funding anymore?

Nov 12, 2024

Seed Funding
Europe’s adversity to risk is why the US is ahead, say experts
Europe’s adversity to risk is why the US is ahead

Nov 5, 2024


Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation
and partnering directly in your inbox.
Stay Updated


C-SUITE CONVERSATIONS

See all
Sponsored Content
[Test][Sherif][Video]
[Test][Sherif][Video]

Oct 28, 2024

CEO of Poseida, Kristin Yarema
VC/PE
Poseida: New CEO, same passion for allogeneic therapies
Poseida: New CEO, same passion for allogeneic therapies

Feb 26, 2024

Dirk Lange
VC/PE
Testing times: MilliporeSigma talks CDMO competition
Testing times: MilliporeSigma talks CDMO competition

Oct 11, 2023





NEWS FROM APAC

See all
Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blastEyes on Asia:
GSK’s $300m lupus bet, Pfizer’s $1bn China blast
byRichard Daverman
Nov 18, 2024
5 Min Read
Eli Lilly logo
Innovation
From east to west: Lilly plans incubators in China and UKFrom east to west:
Lilly plans incubators in China and UK
byMillie Nelson, Richard Daverman
Oct 18, 2024
2 Min Read


partneringONE’s first-in-class partnering technology powers global events and
enhances your networking experience.

LEARN MOREYear-Round Partnering
BioNTech: Partnerships are key to deliver drugs at scale

BioNTech says it is necessary to forge partnerships with health systems to
successfully deliver personalized oncology vaccines at scale.

It’s not me, it’s you! Experts on when you should dump your CDMO

If your CDMO is not willing to change for you then it is time to find someone
else, says experts at Biotech Week Boston (BWB).

BIO-Europe is the premier dealmaking event in Europe.

BIO-Europe November 4-6
Europe’s adversity to risk is why the US is ahead, say experts

Panelists at Bio Europe in Stockholm, Sweden debated whether culture is the main
reason US average funding rounds are double that across the pond.

Inside five innovative research companies driving progress in oncology and
neurology

BIO-Europe Spring 2023's therapeutic focus this year is on the latest innovation
in oncology and neurology. Leading international life science venture capital
firm TVM Capital Life Sciences has multiple investments in these areas. The firm
continues to build its portfolio with new investments from its Life Science
Innovation II fund.




PARTNERING DEALS

See all
Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast

Nov 18, 2024

Deals
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more

Sep 18, 2024

Partnering
Top five Asia biopharma deals: August 2024
Asia biopharma deals: August 2024

Sep 15, 2024

Deals
Eyes on Asia: EpimAb sells T-cell, funding for TargetRx, Hygieai on the siRNA
march
Eyes on Asia: News from EpimAb, TargetRx, Hygieai

Sep 7, 2024


Investival Showcase from LSX logo
Championing life sciences innovators with the ultimate Biotech, Healthtech and
Medtech Networking & Pitching Event. With 8 incredible presenting stages for
startup, growth stage and publicly listed Biotech, Healthtech, Medtech, TechBio,
Digital Health and Deeptech companies.
Register

CONNECT

AboutAdvertise

JOIN US


Stay Updated

FOLLOW US



Copyright © 2024 Informa Connect Limited. Registered in England & Wales with
number 01835199, registered office 5 Howick Place, London, SW1P 1WG.

CCPA: Do not sell my personal info|Terms of Use|Code of Conduct: Events|Privacy
Policy|Cookie Policy